Tuesday, November 17, 2026

The power of algae will change the future of health and the earth|Algalbio selected for JST A-STEP program!

AlgalBio, whose mission is "to contribute to the future of people and the earth through research and development of algae," has been selected by the National Institute of Science and Technology Agency (JST) for the development of "highly functional raw materials using microalgae" under the "Support Program for Optimal Deployment of Research Results"!
As a result, up to ¥330 million in assistance will be provided over a three-year period from August 1, 2025 to July 31, 2028.

Accelerating the practical application of functional raw materials derived from microalgae

(Head office: Kashiwa City, Chiba Prefecture; President: Shu Kimura; hereinafter "AlgalBio"), whose mission is "to contribute to the future of people and the Earth through the research and development of algae," has been selected by the Japan Science and Technology Agency (JST) for the "Support Program for Optimal Exploitation of Research Results (A-STEP (President: Shu Kimura; Head Office: Kashiwa City, Chiba Prefecture; hereinafter referred to as "Algar Bio") has been selected for the "Development of Highly Functional Raw Materials from Microalgae" development project under the "Support Program for Optimal Deployment of Research Results (A-STEP)" (repayment-type) implemented by the National Institute of Science and Technology Development (JST).
As a result, the company plans to receive up to ¥330 million in support over a three-year period from August 1, 2025 to July 31, 2028.

With this support, AlgarBio will work on the development of microalgae-derived raw materials with the aim of notifying them as food with functional claims. Specifically, the company aims to provide new product value derived from algae by acquiring data showing the efficacy of microalgae-derived ingredients, building evidence, elucidating their mechanism of action, and conducting legal and regulatory research for overseas development.

Functional materials derived from AlgarBio's microalgae library

AlgalBio, established in 2018, has built a microalgae biofoundry platform based on over 20 years of microalgae research at the University of Tokyo. utilizing a microalgae library of over 1260 strains of 100 species, we have promoted collaborative research with diverse industrial areas and in FY2024 In FY2024, over 34 joint projects were conducted.

Algar Bio's proprietary microalgae library

In 2023, we released "Moneru," our first in-house developed product containing microalgae selected from our microalgae library. Through participation in research meetings and symposiums attended by physicians and others from medical institutions, the product has been expanded to clinics, and is currently being sold at 80 clinics nationwide. (As of July 31, 2025)
Reference:Algae] was also the topic of Dr. Tomomi Himeno's lecture! Algae supplement Moneru to exhibit at the International Symposium on Nutritional Medicine 2024

Furthermore, in 2025, the production of purely domestic, high-quality, and highly concentrated astaxanthin raw materials by the Japan Biological Science Institute began, utilizing the proprietary microalgae strains and cultivation technology developed by Algar Bio.
Reference:Astaxanthin-rich algae production to be commercialized - Joint development between AlgalBio and the Japan Biological Science Institute comes to fruition

Algar Bio will continue to contribute to improving people's health and quality of life through the discovery and development of functional raw materials using microalgae based on its proprietary "Microalgae Biofoundry Platform".

With the adoption of the JST A-STEP program, we will further accelerate our efforts to quickly commercialize algae raw materials and products with unprecedented high functionality based on scientific evidence, which will be a new option for many more people.

Outline of the Support Program for Optimum Deployment of Research Results (A-STEP)

A-STEP (Assistance Program for the Optimum Deployment of Research Results) is a support program for the practical application of research results obtained at universities and public research institutions in a manner that returns the results to society. The "Support for Implementation (Repayment Type)," which was adopted by AlgarBio, supports technologies that start-up companies aim to implement in society and encourages the creation of innovative products and services.

This program promotes innovation through development loans, aiming for early return of research results to society. Applications are consulted and selected by an evaluation committee composed of outside experts from the perspectives of novelty and superiority of the technological seeds, potential for innovation creation, R&D goals and plans, commercialization potential, financial status, etc., before development support is determined.

Development Overview

Title: "Development of Highly Functional Raw Materials from Microalgae

・Outline: Today's society is highly informatized and globalized through the Internet and smartphones, and a 24-hour society has taken root. In such a society, work and life proceed day and night without distinction, and the quality of sleep and the amount of time spent sleeping are becoming important issues.

According to the results of a 2021 survey by the Organization for Economic Cooperation and Development (OECD), Japan has the shortest average sleep duration among 33 developed countries and is positioned as a country with sleep-related problems worldwide. Furthermore, sleep disorders are becoming more serious in other countries as well, and the market for melatonin, a sleep-inducing drug, is rapidly expanding.

Against this backdrop, conventional insomnia drugs and health foods are widely used as common measures. Insomnia drugs help people fall asleep, but they tend to leave them feeling drowsy when they wake up from sleep, and their rebound effect, in which people are unable to sleep again after discontinuing taking them, is considered problematic. In recent years, insomniacs with fewer side effects have been developed, but the problem of feeling groggy in bed still remains, and a new approach without side effects is needed.

AlgalBio, which took over more than 20 years of algae research at the University of Tokyo, has established a library of more than 1,260 strains of microalgae from 100 species and is conducting further research. Among them, we have discovered a unique microalgae strain that has been shown to reduce inflammatory substances in the brain after oral ingestion in mice. Using this strain, we are developing new solutions to improve sleep and maintain cognitive function.

With the support of this project, AlgarBio will acquire the safety data necessary for notification as a food with functional claims and build evidence of efficacy, as well as elucidate the mechanism of action and conduct regulatory research for overseas development. This will further accelerate efforts toward the early commercialization of algae raw materials and products with high functionality.

Innovation Impact of Microalgae Derived Raw Materials

About AlgalBio, Inc.

Algal Bio Inc. is a research and development venture specializing in the research, development, and commercialization of microalgae.
With the mission of "contributing to the future of people and the Earth through research and development of algae," we aim to give shape to the potential of microalgae.

Based on more than 20 years of algae research at the University of Tokyo, we have established the Microalgae Biofoundry Platform, which includes a library of more than 1,260 strains of microalgae from 100 species, breeding and selection techniques for each species, know-how on designing optimal culture conditions, and a pilot plant that can handle scale-up studies. We also have a pilot plant for scale-up studies.

Utilizing these technologies and infrastructures, we are able to quickly realize everything from the search for the optimal microalgae to its commercialization and commercialization in response to the diverse needs of our clients. Together with a wide variety of partner companies, we promote the creation of new products and solutions utilizing microalgae to address global social issues such as human health, sustainable food supply, and global warming countermeasures.

Algar Bio Inc.

name of companyAlgal Bio Inc.
EstablishmentMar 2018
Location301 Tokatsu Techno Plaza, 5-4-6 Kashiwanoha, Kashiwa-shi, Chiba
representativeShu Kimura
uniform resouce locatorhttps://algalbio.co.jp/

PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。